The impact of HMGCR inhibitor on osteonecrosis through SCGF‐β was found to be indirect with an OR of 0.98 (95% CI, 0.96–0.99; p = 0.04) (Figure 3B). This evidence concerns the gene HMGCR and osteonecrosis.